.svg){kind=small}
Discover opportunities months before the RFP drops
Learn more →Discover opportunities months before the RFP drops
Learn more →Retrieving RFP details
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
Provide online clinical drug information.
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
The U.S. Food and Drug Administration (FDA), Office of Acquisition and Grant Services, issued an RFI on January 5, 2026 to conduct market research on advanced mass spectrometry systems for multiple FDA laboratories. The notice requests voluntary, non-binding technical and business information (responses limited to 20 pages) to inform future acquisition planning and lists requirements for four distinct instrument procurements for FDA facilities. Responses are due February 5, 2026 and should be submitted to Warren Jackson (warren.jackson@fda.hhs.gov); the RFI is informational and not a grant.
Posted Date
Jan 5, 2026
Due Date
Feb 5, 2026
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
Close: Feb 5, 2026
The U.S. Food and Drug Administration (FDA), Office of Acquisition and Grant Services, issued an RFI on January 5, 2026 to conduct market research on advanced mass spectrometry systems for multiple FDA laboratories. The notice requests voluntary, non-binding technical and business information (responses limited to 20 pages) to inform future acquisition planning and lists requirements for four distinct instrument procurements for FDA facilities. Responses are due February 5, 2026 and should be submitted to Warren Jackson (warren.jackson@fda.hhs.gov); the RFI is informational and not a grant.
AvailableThe Department of Energy Office of Science, through Brookhaven National Laboratory (BNL), is seeking a vendor system and service to automatically scrape and distribute job postings. This Request for Information (RFI) aims to distribute postings to various employment service delivery systems and veteran programs. The RFI was posted on January 20, 2026, with responses due by February 6, 2026.
Posted Date
Jan 20, 2026
Due Date
Feb 6, 2026
Release: Jan 20, 2026
Close: Feb 6, 2026
The Department of Energy Office of Science, through Brookhaven National Laboratory (BNL), is seeking a vendor system and service to automatically scrape and distribute job postings. This Request for Information (RFI) aims to distribute postings to various employment service delivery systems and veteran programs. The RFI was posted on January 20, 2026, with responses due by February 6, 2026.
AvailableThe U.S. Food and Drug Administration (FDA) issued an RFI seeking technical and business information from vendors capable of providing advanced mass spectrometry systems (LC-MS/MS, high-resolution MS, and triple quadrupole ICP-MS) to support FDA regulatory and forensic laboratories. The RFI requests responses (not to exceed 20 pages) addressing technical capabilities, instrument specifications, pricing, service models, and experience supporting regulated laboratories, and includes multiple statements of work (SOW) attachments describing system requirements. Responses are voluntary, the government does not intend to award a contract from this RFI, and responses are due Feb 05, 2026 at 10:00 AM EST (15:00:00Z).
Posted Date
Jan 5, 2026
Due Date
Feb 5, 2026
Release: Jan 5, 2026
Close: Feb 5, 2026
The U.S. Food and Drug Administration (FDA) issued an RFI seeking technical and business information from vendors capable of providing advanced mass spectrometry systems (LC-MS/MS, high-resolution MS, and triple quadrupole ICP-MS) to support FDA regulatory and forensic laboratories. The RFI requests responses (not to exceed 20 pages) addressing technical capabilities, instrument specifications, pricing, service models, and experience supporting regulated laboratories, and includes multiple statements of work (SOW) attachments describing system requirements. Responses are voluntary, the government does not intend to award a contract from this RFI, and responses are due Feb 05, 2026 at 10:00 AM EST (15:00:00Z).
AvailableClinical staffing.
Posted Date
Jan 21, 2026
Due Date
Feb 23, 2026
Release: Jan 21, 2026
Close: Feb 23, 2026
Clinical staffing.
AvailableSurface intent from meeting minutes, budgets, and contract expirations. Influence RFP requirements before competitors ever see them.
See your top 10 upcoming opportunities on a demo →